Physician profile
Paul A Latora
NPI 1346254638
$2,569.41
in general payments reported to CMS, 2019-2025
30 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.15 · 2020: $443 · 2021: $460 · 2022: $290 · 2023: $297 · 2024: $587 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $362.59 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $333.44 | 2019-2025 | Stravix Pl, Grafix Pl, Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $318.62 | 2020-2021 | |
| Organogenesis INC. | $253.41 | 2020-2025 | Apligraf |
| Abbvie INC. | $197.30 | 2021-2024 | |
| Acera Surgical, INC. | $140.98 | 2022-2024 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $110.34 | 2022 | |
| Urgo Medical North America, LLC | $104.85 | 2024 | Urgoclean Ag |
| Ets Wound Care LLC | $103.61 | 2024 | Mirragen Advanced Wound Matrix |
| Polarityte, INC. | $93.86 | 2021 | |
| Convatec INC. | $88.09 | 2023 | |
| Zimmer Biomet Holdings, INC. | $52.59 | 2023 | Genex |
| Stryker Corporation | $51.78 | 2025 | Augment Injectable |
| Solventum Corporation | $36.04 | 2024-2025 | Activ.A.C., V.A.C.Ulta, Prevena |
| Next Science LLC | $35.15 | 2023 | Blastx, Surgx, Xperience |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $29.30 | 2022-2025 | Nuzyra |
| Horizon Therapeutics Plc | $25.18 | 2021 | |
| Orthofix Medical, INC. | $22.65 | 2024 | Physio-Stim |
| Reprise Biomedical, INC. | $22.33 | 2024 | Miro3d |
| Advanced Oxygen Therapy INC. | $20.43 | 2024 | Topical Oxygen Chamber For Extremities |
| Kci USA, INC. | $20.29 | 2023 | Activ.A.C. |
| Averitas Pharma INC. | $17.88 | 2025 | Qutenza |
| Royal Biologics, INC. | $17.77 | 2021 | |
| Melinta Therapeutics, LLC | $17.24 | 2023 | Orbactiv, Kimyrsa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.22 | 2022 | |
| Hydrofera LLC | $16.82 | 2024 | Hydrofera Blue |
| Lifenet Health | $16.50 | 2025 | Theragenesis Wound Matrix |
| Bone Support INC. | $15.69 | 2024 | Cerament G, Ceramentbone Void Filler |
| Merck Sharp & Dohme LLC | $13.89 | 2019 | |
| Nevro Corp. | $13.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Latora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.